Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Chlosta

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Urologic Oncology|November 15, 2020
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, David D Andrea, Fahad Quhal, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Cancers|January 25, 2025
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate CancerAkihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Frontiers in Surgery|July 18, 2022
Telemedicine and Telehealth in Urology: Uptake, Impact and Barriers to Clinical AdoptionNithesh Naik, Shreyas Raghavan Nandyal, Sanjana Ganesh Nayak, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2021
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancerVictor M Schuettfort, Benjamin Pradere, Quoc-Dien Trinh, et al.
European Urology Focus|January 23, 2025
Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysisAkihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Urologic Oncology|November 15, 2020
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, David D Andrea, Fahad Quhal, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Cancers|January 25, 2025
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate CancerAkihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Frontiers in Surgery|July 18, 2022
Telemedicine and Telehealth in Urology: Uptake, Impact and Barriers to Clinical AdoptionNithesh Naik, Shreyas Raghavan Nandyal, Sanjana Ganesh Nayak, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2021
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancerVictor M Schuettfort, Benjamin Pradere, Quoc-Dien Trinh, et al.
European Urology Focus|January 23, 2025
Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysisAkihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
Pageof 11